| Product Code: ETC9963824 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The United States saw a decline in cyclosporine import shipments in 2024, with top exporting countries including Switzerland, Ireland, Singapore, India, and Germany. Despite the negative compound annual growth rate (CAGR) of -2.97% from 2020 to 2024 and a significant growth rate decrease of -24.21% from 2023 to 2024, the market remained relatively unconcentrated with a low Herfindahl-Hirschman Index (HHI) in 2024. This data suggests a shifting landscape in cyclosporine imports, potentially influenced by various factors impacting global trade dynamics.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Cyclosporine Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Cyclosporine Market Revenues & Volume, 2022 & 2032F |
3.3 United States (US) Cyclosporine Market - Industry Life Cycle |
3.4 United States (US) Cyclosporine Market - Porter's Five Forces |
3.5 United States (US) Cyclosporine Market Revenues & Volume Share, By Indication, 2022 & 2032F |
3.6 United States (US) Cyclosporine Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.7 United States (US) Cyclosporine Market Revenues & Volume Share, By End-Users, 2022 & 2032F |
3.8 United States (US) Cyclosporine Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 United States (US) Cyclosporine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of autoimmune diseases requiring cyclosporine treatment |
4.2.2 Growing geriatric population in the United States |
4.2.3 Technological advancements in drug delivery methods for cyclosporine |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and marketing of cyclosporine products |
4.3.2 High cost associated with cyclosporine therapy |
4.3.3 Potential side effects and risks associated with long-term use of cyclosporine |
5 United States (US) Cyclosporine Market Trends |
6 United States (US) Cyclosporine Market, By Types |
6.1 United States (US) Cyclosporine Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Cyclosporine Market Revenues & Volume, By Indication, 2022 - 2032F |
6.1.3 United States (US) Cyclosporine Market Revenues & Volume, By Transplant Rejection Prophylaxis, 2022 - 2032F |
6.1.4 United States (US) Cyclosporine Market Revenues & Volume, By Rheumatoid Arthritis, 2022 - 2032F |
6.1.5 United States (US) Cyclosporine Market Revenues & Volume, By Psoriasis, 2022 - 2032F |
6.1.6 United States (US) Cyclosporine Market Revenues & Volume, By Autoimmune Myasthenia Gravis, 2022 - 2032F |
6.1.7 United States (US) Cyclosporine Market Revenues & Volume, By Dry Eye, 2022 - 2032F |
6.1.8 United States (US) Cyclosporine Market Revenues & Volume, By Others, 2022 - 2032F |
6.2 United States (US) Cyclosporine Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Cyclosporine Market Revenues & Volume, By Oral, 2022 - 2032F |
6.2.3 United States (US) Cyclosporine Market Revenues & Volume, By Injectable, 2022 - 2032F |
6.2.4 United States (US) Cyclosporine Market Revenues & Volume, By Topical, 2022 - 2032F |
6.3 United States (US) Cyclosporine Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Cyclosporine Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.3.3 United States (US) Cyclosporine Market Revenues & Volume, By Homecare, 2022 - 2032F |
6.3.4 United States (US) Cyclosporine Market Revenues & Volume, By Speciality Centres, 2022 - 2032F |
6.3.5 United States (US) Cyclosporine Market Revenues & Volume, By Others, 2022 - 2032F |
6.4 United States (US) Cyclosporine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Cyclosporine Market Revenues & Volume, By Hospital Pharmacy, 2022 - 2032F |
6.4.3 United States (US) Cyclosporine Market Revenues & Volume, By Online Pharmacy, 2022 - 2032F |
6.4.4 United States (US) Cyclosporine Market Revenues & Volume, By Retail Pharmacy, 2022 - 2032F |
7 United States (US) Cyclosporine Market Import-Export Trade Statistics |
7.1 United States (US) Cyclosporine Market Export to Major Countries |
7.2 United States (US) Cyclosporine Market Imports from Major Countries |
8 United States (US) Cyclosporine Market Key Performance Indicators |
8.1 Number of new FDA approvals for cyclosporine-based products |
8.2 Patient adherence and compliance rates to cyclosporine therapy |
8.3 Research and development investment in cyclosporine-related innovations |
8.4 Number of clinical trials investigating new indications for cyclosporine |
9 United States (US) Cyclosporine Market - Opportunity Assessment |
9.1 United States (US) Cyclosporine Market Opportunity Assessment, By Indication, 2022 & 2032F |
9.2 United States (US) Cyclosporine Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.3 United States (US) Cyclosporine Market Opportunity Assessment, By End-Users, 2022 & 2032F |
9.4 United States (US) Cyclosporine Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 United States (US) Cyclosporine Market - Competitive Landscape |
10.1 United States (US) Cyclosporine Market Revenue Share, By Companies, 2025 |
10.2 United States (US) Cyclosporine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here